Who owns CHEMOMAB THERAPEUTICS LTD SPONSORED ADS?

Tip: Access positions for across all investors

Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Chemomab Therapeutics stock

Who bought or sold CHEMOMAB THERAPEUTICS LTD SPONSORED ADS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Sphera Funds Management 179k $472k 100% Sep 2025
 View chart
Ikarian Capital 53k $140k 100% Sep 2025
 View chart
Stonepine Capital Management 30k $79k 100% Sep 2025
 View chart
Jane Street 22k $57k 100% Sep 2025
 View chart
Rhumbline Advisers 9.5k $25k 100% Sep 2025
 View chart
Bnp Paribas Arbitrage, Snc 5.8k $15k 100% Sep 2025
 View chart
GAMMA Investing 667.00 $1.8k 100% Sep 2025
 View chart
UBS Group 99.00 $260.003700 100% Sep 2025
 View chart
SBI Securities 26.00 $68.000400 100% Sep 2025
 View chart